Two monoclonal antibody treatments to slow Alzheimer’s disease, lecanemab (Leqembi) and donanemab (Kisunla), have been approved by the U.S. Food and Drug Administration over the past two years. It’s thought the drugs curb Alzheimer’s by reducing levels of toxic amyloid protein plaques in the brain. But what if another neurological effect could explain the benefit?… read on > read on >
Black stroke victims are arriving at emergency rooms much later than white patients, greatly increasing their risk of death or lifelong disability, a new study finds. Every second counts when it comes to treating a stroke, experts say. Any moment’s delay allows for more brain damage to occur, and patients could arrive too late for… read on > read on >
Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows. The drugs’ active ingredient, semaglutide, reduced heart health risk by 20% in heavyset people who took it for more than three years, researchers reported Wednesday at the European Association for… read on > read on >
Less than half of people who’ve survived a stroke will go on to have a healthy, normal sleep pattern, new research shows. Normal sleep is defined as six to eight hours of shuteye nightly. However, a majority of the nearly 1,600 stroke survivors in the new study got either too much or too little sleep.… read on > read on >
As fears of the consequences of an unintended pregnancy rose after Roe v. Wade was overturned in 2022, rates of surgical sterilization rose in those states most affected by the decision, new research shows. Rates of tubal sterilization — tying, cutting or removing the fallopian tubes — rose by an average 3% per month in… read on > read on >
The U.S. Food and Drug Administration announced Tuesday that it will launch an independent review into any possible effects of toxic metals found in tampons. The announcement follows the release of a study in July that found traces of lead and other metals in 30 tampons from 14 brands obtained from major online retailers and… read on > read on >
The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report. The findings, published Tuesday in the New England Journal of Medicine and presented simultaneously at the European Association for the Study of Diabetes annual meeting in Madrid, are the first to demonstrate the effects of liraglutide (Saxenda) on children… read on > read on >
An experimental weight-loss pill appears to help people quickly shed pounds, a new study says. People who took the drug amycretin lost up to 13% of their body weight over three months, according to early clinical trial results presented at the European Association for the Study of Diabetes annual meeting in Madrid. Amycretin mimics the… read on > read on >
In the two years since the March of Dimes’ last report on the state of U.S. maternity care, more than 100 hospitals nationwide have shuttered their obstetric units, leaving more new moms with literally “Nowhere to Go” for care. The March of Dimes’ 2024 report, titled “Nowhere to Go: Maternity Care Deserts Across the U.S.,”… read on > read on >
Weekly insulin shots can help control both type 1 and type 2 diabetes as well as daily injections do, a pair of clinical trials have found. A new class of insulin called efsitora alfa has been designed to require injections only once a week, researchers said. Two phase 3 trials presented Tuesday at the European… read on > read on >
